Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer.

Etienne GoutonNausicaa Malissen Anne Isabelle BertozziArnaud JeansonAnnick PelletierAlbane Testot-FerryCaroline Gaudy-MarquesteLaetitia DahanEmeline TabouretThomas ChevalierLaurent GreillierPascale Tomasini

Published in: Current oncology (Toronto, Ont.) (2022)

Routine cfDNA molecular profiling is feasible and can lead to the access of targeted therapies. However, no notable benefit in patient's outcomes was shown in this unselected pan-cancer study.

Keyphrases

papillary thyroid
high throughput sequencing
squamous cell
case report
single cell
lymph node metastasis
clinical practice
adipose tissue
single molecule
insulin resistance
weight loss